Safety of IVIG made from HCV-antibody-screened plasma
- 26 October 1991
- journal article
- other
- Published by Elsevier in The Lancet
- Vol. 338 (8774), 1076
- https://doi.org/10.1016/0140-6736(91)91931-j
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Long-term safety and tolerability of intravenous immunoglobulinThe Lancet, 1991
- Anti-HCV screening and plasma fractionation: the case againstThe Lancet, 1990
- Screening for hepatitis C virus antibody in plasma for fractionationThe Lancet, 1990
- Screening for hepatitis C virus antibody in plasma for fractionationThe Lancet, 1990
- DECREASED INCIDENCE OF ADVERSE INFUSION REACTIONS IN HYPOGAMMAGLOBULINEMIC CHILDREN RECEIVING LOW pH INTRAVENOUS IMMUNOGLOBULINAustralian and New Zealand Journal of Medicine, 1987
- NON-A, NON-B HEPATITIS AFTER INTRAVENOUS GAMMAGLOBULINThe Lancet, 1986
- NON-A, NON-B HEPATITIS OCCURRING IN AGAMMAGLOBULINAEMIC PATIENTS AFTER INTRAVENOUS IMMUNOGLOBULINThe Lancet, 1984